EUVIMEDEUVIMED entdecken
Crossref

P1.242. One-Year Overall and Disease-Free Survival After Uniportal Robotic-Assisted Minimally Invasive Esophagectomy

Ting-Fang Kuo, Jang-Ming Lee

Diseases of the Esophagus · 22.08.2026 · 39 (Supplement_1)

DOI: 10.1093/dote/doag077.390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 22.08.2026. Verfasst von Ting-Fang Kuo und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – technique Background Uniportal robotic-assisted minimally invasive esophagectomy has demonstrated perioperative safety in preliminary experience; however, its oncologic outcomes remain to be established. This study aimed to evaluate one-year overall survival and disease-free survival after uniportal robotic-assisted minimally invasive esophagectomy.

Methods

Patients who underwent uniportal robotic-assisted minimally invasive esophagectomy between September 2024 and July 2025 were retrospectively reviewed. The primary outcome was one-year overall survival and disease-free survival. Oncologic adequacy, including the complete resection rate with microscopically negative margins and lymph node yield, was also assessed. Perioperative outcomes were analyzed descriptively.

Results

Twenty-one patients underwent uniportal robotic-assisted minimally invasive esophagectomy. Squamous cell carcinoma accounted for 81%, and 62% had stage III–IV disease; 71% received neoadjuvant therapy. Complete resection with microscopically negative margins was achieved in 95%, with a median lymph node yield of 34. At a median follow-up of 11.1 months, the overall survival and disease-free survival for the entire cohort were 83% and 76%, respectively. In stage I–II disease, both overall survival and disease-free survival were 100%. In stage III–IV disease, overall survival and disease-free survival were 74% and 62%, respectively.

Conclusion

Uniportal robotic-assisted minimally invasive esophagectomy is feasible and demonstrates encouraging early oncologic outcomes, even in a cohort with predominantly advanced-stage disease.

Zitieren

APA

Kuo, T., & Lee, J. (2026). P1.242. One-Year Overall and Disease-Free Survival After Uniportal Robotic-Assisted Minimally Invasive Esophagectomy. Diseases of the Esophagus, 39(Supplement_1). https://doi.org/10.1093/dote/doag077.390

Vancouver

Kuo T, Lee J. P1.242. One-Year Overall and Disease-Free Survival After Uniportal Robotic-Assisted Minimally Invasive Esophagectomy. Diseases of the Esophagus. 2026;39(Supplement_1). doi:10.1093/dote/doag077.390

BibTeX
@article{Kuo2026,
  author = {Kuo, Ting-Fang and Lee, Jang-Ming},
  title = {P1.242. One-Year Overall and Disease-Free Survival After Uniportal Robotic-Assisted Minimally Invasive Esophagectomy},
  journal = {Diseases of the Esophagus},
  year = {2026},
  volume = {39},
  number = {Supplement_1},
  doi = {10.1093/dote/doag077.390}
}
Kostenlos starten →